The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH MM 2018 | How do we define a ‘cure’ in myeloma?
Annemiek Broyl
• 6 Oct 2018
How to we define a ‘cure’ in multiple myeloma (MM)? We spoke to Annemiek Broyl, MD, PhD, of Erasmus Medical Center and University, Rotterdam, Netherlands, about this important and interesting topic, as well as the role of measurable residual disease (MRD) in this definition, at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.
